Document:

EX-10.3

 Exhibit 10.3 

CANAAN INC. 
 FORM OF
EXECUTIVE EMPLOYMENT AGREEMENT 
 This Executive Employment Agreement, dated as of
                , 20     (this “Agreement”), is executed by and between Canaan Inc., an exempted company with limited liability
incorporated and existing under the laws of the Cayman Islands (the “Company”) and                  (holding passport of
                 with passport number of                 /PRC Identification Card
No.                                        ) (the
“Executive”). 
 RECITALS 

The Company desires to employ the Executive, and the Executive agrees to be employed by the Company, and act as
                 of the Company, all pursuant to the terms and conditions of this Agreement; 

NOW, THEREFORE, the parties hereto agree as follows: 
  

	1.	 TERM OF EMPLOYMENT 

 

	 	1.1	 The Company shall employ the Executive to take the position as set forth in Article 2 hereof, perform the
duties and responsibilities as set forth in Article 2 hereof, and render services to the Company during a term of five (5) years commencing
on                        , 20     and ending
on                        , 20     (the “Term”) . The Term may be early terminated pursuant to the
provisions of Articles 4 and 5 hereof. 

  

	2.	 POSITION, DUTIES AND RESPONSIBILITIES 

 

	 	2.1	 Position. The Executive shall be employed and act as
the                                 of the Company with all responsibilities that are
customary for such officer, as well as other responsibilities reasonably assigned to the Executive by the Company. The Executive may take position in any Affiliate (as defined in Article 2.2 hereof) of the Company. The entity in which the Executive
takes position and the location where the Executive works may be appropriately adjusted according to the operative demands of the Company in the future. The Executive shall use his/her best efforts to perform his/her duties and shall comply with all
applicable laws, regulations and rules as well as the memorandum and articles of association and corporate and business policies and procedures of the Company. The Executive shall adhere to good business ethics and practices and shall not take
advantage of his/her position for personal gains. 

  

	 	2.2	 For the purpose of this Agreement, “Affiliate” means any entity directly or indirectly controlled by
the Company. For the purpose of this Article, “Control” means the direct or indirect possession of the power to direct or cause to direct the management and policies of such entity, whether through ownership of voting securities, by
contract or otherwise, including, without limitation, (a) the direct or indirect ownership of 50% or more of the outstanding stocks or other equity interests issued by such entity, (b) direct or indirect ownership of the 50% or more voting
power of such entity, or (c) the power to appoint, directly or indirectly, a majority of the members of the board of directors or other similar decision-making organization of such entity. 

	 	2.3	 Voting Restriction. If the Executive is elected as a director of the Company, the Executive shall
refrain from voting, in his/her capacity of a director of the Company, on matters in relation to his/her employment or termination of his/her employment at meetings of the board of directors of the Company. 

 

	 	2.4	 Other Activities. Except with the prior written approval of the Company, the Executive shall not render
commercial or professional services of any nature to any person or organization, whether or not for compensation; and the Executive will not directly or indirectly engage, participate, invest, finance or otherwise assist in any business activity
that is potentially competitive in any manner with the business of the Company or any Affiliate or any business activity that may cause the Executive to be in conflict of interest with the Company or any Affiliate, whether or not for profit.

  

	3.	 COMPENSATION AND BENEFITS 

As full consideration for the services to be provided by the Executive under this Agreement and as full compensation for the obligations and
restrictions to be imposed on the Executive by this Agreement, the Company shall or have its Affiliate in which the Executive holds a position, as the case may be, pay the Executive, and the Executive agrees to accept, the base salary, bonus, share
option and other incentive programs, and other benefits as set forth in this Article 3. 
  

	 	3.1	 Base salary. The Company shall pay base salaries to the Executive in the amount and by the means as set
forth in Part I of Exhibit A hereof. 

  

	 	3.2	 Bonus. The Executive may be entitled to the performance-based bonus as set forth in Part II of Exhibit A
hereof. 

  

	 	3.3	 Share Options and Other Incentive Programs. The Executive shall be eligible to participate in any share
option or other incentive program available to officers or employees of the Company as determined by the Company. 

  

	 	3.4	 Benefits. The Executive will be eligible to receive any benefit as the Company or the Affiliate with
which the Executive works generally provides to its other employees of comparable position in accordance with the benefit plans established and amended from time to time at its sole discretion by the Company or such Affiliate, including without
limitation, various mandatory health care, insurance and pension plans required in the jurisdiction where the Company or such Affiliate is located. The annual paid leave of the Executive shall be twenty (20) working days. 

  
 2 

	4.	 TERMINATION BY THE COMPANY. 

 

	 	4.1	 Termination for Cause. For purposes of this Agreement, unless otherwise provided under applicable laws,
“Cause” will exist at any time after the occurrence of one or more of the following events: (a) the Executive commits willful misconduct or gross negligence in performance of his duties hereunder (“Malfeasance”) and fails to
correct such Malfeasance within a reasonable period specified by the Company after the Company has sent the Executive a written notice demanding correction within such a period; (b) the Executive has committed Malfeasance and has caused serious
losses and damages to the Company; (c) the Executive seriously violates the internal rules of the Company and fails to correct such violation within a reasonable period specified by the Company after the Company has sent the Executive a
written notice demanding correction within such a period; (d) the Executive has seriously violated the internal rules of and has caused serious losses and damages to the Company; (e) the Executive is convicted by a court of competent
jurisdiction or has pleaded guilty of theft, fraud or other criminal offense; or (f) the Executive seriously breaches his/her duty of loyalty to the Company or an Affiliate under the laws of the Cayman Islands, the PRC or other relevant
jurisdictions. The Company may terminate the employment of the Executive for Cause at any time without prior written notice. Upon termination, the Company shall pay all compensation of the Executive accrued up to the date of termination pursuant to
Article 3 hereof and severance payments as expressly required by applicable law; provided, however, that the Company may deduct and withhold any amount it is entitled to as damages under applicable laws. Thereafter, all obligations of the
Company under this Agreement shall terminate. 

  

	 	4.2	 Termination without Cause. The Company may terminate the Executive’s employment by a three-month
prior written notice. Upon termination, the Company shall pay all compensation of the Executive accrued up to the date of termination pursuant to Article 3 hereof; provided, however, that the Company may deduct and withhold any amount it is entitled
to as damages under applicable laws. Thereafter, all obligations of the Company under this Agreement shall terminate. 

  

	 	4.3	 Termination By Reason of Death. The employment of the Executive by the Company shall be automatically
ceased upon the death of the Executive. In the event that employment of the Executive by the Company terminates as a result of the Executive’s death, the Executive’s estate or heirs will receive all unpaid compensation accrued as of the
date of the termination of the employment as provided in Article 3 hereof; provided that, the Company may deduct and withhold any amount it is entitled to as damages under applicable laws. Thereafter, all obligations of the Company under this
Agreement shall terminate. Nothing contained herein shall prevent the estate or heirs of the Executive from being entitled to any interest or other applicable benefits under any life insurance programs (if any). If the death of the Executive occurs
during the performance of his/her duties for the Company, the Company shall pay to the appropriate beneficiaries a special compensation at an amount to be determined by the Company which shall not exceed the annual base salary of the Executive as
set forth in Article 3.1 hereof. 

  
 3 

	 	4.4	 Termination By Reason of Disability. In the event that the Executive is entitled to long-term disability
benefits of the Company, or in the event that, in the judgment of the Company, the Executive is not able to perform his/her duties for 90 consecutive days or 120 days or longer in a 12-month period due to
his/her physical or psychological problems, the Company may terminate the Executive’s employment, provided that such termination is permitted by the law. Upon termination, the Company shall pay all compensation of the Executive accrued up to
the date of termination pursuant to Article 3 hereof; provided, however, that the Company may deduct and withhold any amount it is entitled to as damages under applicable laws. Thereafter, all obligations of the Company under this Agreement shall
terminate. The provisions of this Article 4.3 shall not affect the Executive’s rights under any disability program that he/she participates (if any). 

  

	5.	 TERMINATION BY THE EXECUTIVE 

 

	 	5.1	 The Executive may voluntarily terminate his/her employment with the Company with or without cause by a
three-month prior written notice. During such three-month notice period, the Executive shall continue to perform diligently his/her duties and responsibilities under this Agreement. The Company shall have the discretion to terminate its employment
with the Executive prior to the last day of such three-month period; provided that the Company shall have paid the Executive all of his/her compensation accrued through the last day of such three-month period pursuant to Article 3 hereof; provided
further that the Company may deduct and withhold any amount it is entitled to as damages under applicable laws. Thereafter, the Company’s obligations hereunder shall terminate. In such case, the Company shall not be responsible for paying any
severance pay or other benefits to the Executive. 

  

	6.	 RESPONSIBILITIES UPON TERMINATION 

 

	 	6.1	 Return of Documents. The Executive agrees to promptly return to the Company all documents and materials
in any form received by the Executive by virtue of his/her employment with the Company upon or prior to the termination of his/her employment with the Company, including, without limitation, all originals and copies of any Proprietary Information as
defined in Article 8 hereof as well as any part thereof, together with all equipment and other tangible or intangible assets of the Company. The Executive agrees not to retain any document or material that contains such Proprietary Information or
any copy thereof. 

  
 4 

	 	6.2	 Survival. The Executive further agrees that (a) all representations, warranties and obligations
under Articles 6, 7, 8, 9, 11 and 14 hereof shall survive the termination or expiration of the Term; (b) all representations, warranties and obligations under Articles 6, 7, 8, 9, 11 and 14 hereof shall also survive the termination of this
Agreement; and (c) after termination or expiration of the Term, the Executive shall use his/her best efforts to cooperate with the Company in connection with such surviving obligations, including, without limitation to, completion of
outstanding work on behalf of the Company, transfer of his/her assignments to designated employees of the Company, and defense of the Company against claims raised by any third party in connection with any action or negligence of the Executive
during his employment with the Company. 

  

	7.	 RESTRICTED ACTIVITIES 

 

	 	7.1	 No-use of Proprietary Information. The Executive acknowledges
that to conduct any activity restricted in this Article will certainly involve the use or disclosure of Proprietary Information as defined in Article 8 hereof and consequently result in a breach of such Article, and it will be difficult to directly
demonstrate a breach of Article 8 hereof. Therefore, in order to prevent the Executive from using or disclosing the Proprietary Information as defined in Article 8 and as a condition to employing the Executive, the Executive agrees that during
his/her employment with the Company and for a period of one year after the termination or expiration of the employment, the Executive shall not, directly or indirectly: 

 

	 	(a)	 refer or attempt to refer to any third party any business in which the Company or its Affiliates currently
engage or will likely engage or participate, including, without limitation, solicitation or provision of any business or services that are essentially similar to the business of the Company or its Affiliates on behalf of any individual, company or
other entity who was then an existing or prospective customer, supplier or partner of the Company or its Affiliates. 

  

	 	(b)	 seek to solicit the services of any employees who is employed by the Company or its Affiliates on or after the
date of the Executive’s termination, or in the year preceding such termination, without the prior written consent of the Company. 

  

	 	7.2	 Non-Competition 

 

	 	(a)	 During the Restrictive Period set forth in Article 7.2(b) hereof, the Executive shall not, directly or
indirectly, engage in any manner in any business that may compete with the business of the Company anywhere in the world, and without the prior written consent of the Company, the Executive shall not, directly or indirectly, anywhere in the world,
own an interest in, manage, operate, join, control, lend money or render financial or other assistance to or participate in or be connected with, as an officer, employee, partner, stockholder, principal, licensor, consultant or otherwise, any person
that competes with the Company. During the Restrictive Period, the Executive shall not approach financial institutions, dealers or other persons or entities introduced to the Executive in his or her capacity as a representative of the Company for
the purpose of doing business with such persons or entities that will harm the Company’s business relationships with these persons or entities. 

  
 5 

	 	(b)	 In this Article 7.2, “Restricted Period” shall mean the Term of this Agreement and one (1) year
after the expiration or early termination thereof. 

  

	 	(c)	 In the event that the Executive is in breach of the provisions of Article 7.2(a) hereof, the Restricted Period
shall be extended by the length of the period of such breach. 

  

	 	(d)	 The Executive acknowledges that the compensation to be paid by the Company shall have contained any and all
economic consideration for each and all obligations of the Executive under this Article 7.2. 

  

	 	7.3	 Enforceability. Each covenant contained in this Article 7 constitutes an independent covenant, and if
any covenant in unenforceable, other covenants shall continue to be valid and binding. In the event the term of any restriction or the territorial restriction contained in this Article 7 is finally determined by a competent court to have exceeded
the maximum extent deemed reasonable and enforceable by such court, then this Agreement shall be amended as such to adopt the longest term or largest territory deemed by such court to be enforceable. 

 

	 	7.4	 Independent Covenant. All covenants contained in this Article 7 shall be interpreted as a separate
agreement independent of other provisions of this Agreement. Any lawsuit or claim brought by the Executive against the Company (whether by virtue of this Agreement or any other agreement) shall not constitute a defense against the enforcement of
this Article 7 by the Company. 

  

	8.	 PROPRIETARY INFORMATION 

 

	 	8.1	 The Executive agrees that during his/her employment with the Company and within two (2) years after
termination of his/her employment with the Company, he/she will keep in strict confidence all Proprietary Information and, without the prior written consent of the Company, will not use or disclose to any individual, entity or company the
Proprietary Information other than the use or disclosure for the purposes of performing his/her duties and responsibilities and in favor of the Company or pursuant to applicable law to the extent necessary. “Proprietary Information”
shall mean any proprietary, confidential or secret information disclosed to the Executive in connection with the Company, the business of the Company, or subsidiaries, Affiliates, customers or business partners of the Company or their respective
businesses, or any third party to which the Company has confidentiality obligation (the “Related Party”) or its business. Such Proprietary Information shall include, without limitation, trade secrets, manuals, hardware, customers’
personal information, terms of business agreements and contracts, research materials, business strategies, personnel information, market information, technical materials, forecasts, promotion, financial and other business information of the Company
or the Related Parties, no matter such information is directly or indirectly disclosed to the Executive in writing, orally, in the form of image or object or otherwise. The Executive understands that the Proprietary Information does not include any
of the foregoing that has become known to the public other than as a result of disclosure by the Executive in breach hereof. 

  
 6 

	9.	 INTELLECTUAL PROPERTY 

 

	 	9.1	 Inventions Retained and Licensed. Exhibit B of this Agreement sets forth all inventions which were made
by the Executive prior to his/her employment with the Company (collectively, the “Prior Inventions”), including all processes, inventions, technology, original works of authorship, developments, improvements, formulas, patents,
discoveries, copyrights and trade secrets. Such Prior Inventions, which belong to the Executive and are related to the Company’s proposed business, products or research and development, are not assigned to the Company hereunder. In case that
there is no Prior Invention listed in Exhibit B hereof, the Executive hereby confirms that no Prior Invention exist. If in the course of his/her employment with the Company, the Executive incorporates into a Company product, process, machine or
other project a Prior Invention owned by the Executive or in which the Executive has an interest, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use,
sell and engage in other actions with respect to such Prior Invention as part of or in connection with such product, process or machine. 

  

	 	9.2	 Assignment of Inventions. The Executive agrees that he/she will promptly make full written disclosure to
the Company in confidence, will hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, without further compensation, all his/her right, title, and interest in and to any and all inventions,
designs, original works of authorship, developments, concepts, improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws, which the Executive may solely or jointly conceive or develop or reduce to
practice, or cause to be conceived or developed or reduced to practice, during the period of time the Executive is in the employment of the Company and within twelve (12) months after the termination or expiration of the employment
(collectively referred to as “Inventions”), except as provided in Article 9.3 below. The Executive further agrees to use best efforts to assist the Company in obtaining and enforcing patents, copyrights and other legal rights for these
Inventions. The Executive further agrees that all patentable and copyrightable works which are made by the Executive (solely or jointly with others) within the scope of and during the period of his/her employment with the Company, are “works
made for hire” and the Executive hereby assigns all proprietary rights, including patent and copyright, in these works to the Company without further compensation. 

  
 7 

	 	9.3	 Unrelated Inventions. Inventions as referenced to in Article 9.2 hereof does not include inventions
which the Executive can demonstrate to be developed entirely on his/her own time without using the Company’s equipment, supplies, facilities or trade secret information (the “Unrelated Inventions”), unless those inventions that are
either (i) related at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or development of the Company, or (ii) result from any work performed by
Executive for the Company. The Executive agrees to disclose promptly to the Company all such Unrelated Inventions and to provide the Company or its assignee first rights of refusal to license such disclosed Unrelated Inventions within three
months after his/her disclosure of such Unrelated Inventions based on commercially negotiated terms. 

  

	 	9.4	 Maintenance of Records. The Executive agrees to keep and maintain adequate and current written records
of all Inventions made by the Executive (solely or jointly with others) during the term of his/her employment with the Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company.
The records will be available to and remain the sole property of the Company at all times. 

  

	 	9.5	 Patent and Copyright Registrations. 

 

	 	(a)	 The Executive agrees to assist the Company, or its designee, upon the instruction of the Company, in every
proper way to secure the Company’s rights in the Inventions and any copyrights, patents or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent information and
data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the
Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents or other intellectual property rights relating thereto. 

 

	 	(b)	 The Executive further agrees that his/her obligation to execute or cause to be executed any such instrument or
papers shall continue after the termination of this Agreement. If the Company is unable because of the Executive’s mental or physical incapacity or for any other reason to secure his/her signature to apply for or to pursue any application for
any domestic or foreign patents or copyright registrations covering Inventions assigned to the Company as above, then the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as his/her agent
and attorney in fact, to act for and in his/her behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with
the same legal force and effect as if executed by the Executive. 

  
 8 

	10.	 INFORMATION OF PREVIOUS EMPLOYER 

 

	 	10.1	 The Executive agrees that during his/her employment with the Company he/she will not inappropriately use or
disclose any proprietary information or trade secrets owned by any previous employer of the Executive or any other individual or entity obtained prior to his/her employment with the Company, nor will he/she bring to the Company any such non-public document or proprietary information. 

  

	11.	 INFORMATION OF THIRD PARTIES 

 

	 	11.1	 The Executive hereby acknowledges that the Company has received and may continue to receive from third parties
confidential or proprietary information. The Executive agrees to keep in strict confidence all of such confidential or proprietary information in his/her possession and to refrain from using or disclosing to any individual, entity or company such
confidential or proprietary information, except that such use or disclosure is in compliance with the agreement between the Company and such third party and is necessary for the performance of relevant work on behalf of the Company.

  

	12.	 NO-CONFLICT 

 

	 	12.1	 The Executive represents and warrants that the execution by the Executive of this Agreement, the employment
with the Company, and the performance by the Executive of his/her duties and responsibilities pursuant to this Agreement will not breach any of his/her legal or contractual obligation to any prior employer of the Executive or any other parties,
including, without limitation, any obligation in respect of proprietary or confidential information or intellectual property rights of such party. 

  

	13.	 FOREIGN CORRUPTION ACT 

 

	 	13.1	 The Executive agrees to diligently adhere to the Foreign Corrupt Practices Act attached as Exhibit E hereof.

  

	 	13.2	 The Executive agrees and promises not to provide or offer any remuneration, gift, service or article of value
to any government officials (including working stuff or employees of any government or administrative agencies, political parties or candidates) of any country for any reason. The Executive further agrees and promises that the Executive will not
accept any remuneration in the form of cash or other tangible objects from any person in performing his/her duties under this Agreement other than the compensation specified in Article 3 of this Agreement. The Executive promises that all conducts of
the Executive under this Agreement shall be in compliance with all relevant laws, regulations and administrative rules of the People’s Republic of China at all times. 

  
 9 

	14.	 MISCELLANEOUS 

 

	 	14.1	 Continuing Obligation. If the Executive is employed by any existing or future Affiliate of the Company
at any time, or provides services to such Affiliate, or otherwise retained by such Affiliate, then the obligations under this Agreement shall continue to apply. Any reference to the Company shall include such Affiliate. In the event that this
Agreement expires or terminates for any reason, the Executive shall immediately resign from any position at such Affiliate of the Company, unless otherwise required by the Company. 

 

	 	14.2	 Notice to Employer. The Executive hereby authorizes the Company to notify the relevant provisions of
this Agreement and the Executive’s obligations under this Agreement to the actual or future employer of the Executive (including the Affiliate with which the Executive will work). 

 

	 	14.3	 Right to Name and Image. The Executive hereby authorizes the Company to use, or authorize any other
person to use, once or from time to time during his/her employment with the Company, the names, photos, images (including cartoons), voices and resume of the Executive as well as photocopies and duplicates thereof in any media now known or developed
in the future (including but not limited to movies, videos, digital or any other electronic media) for purposes as may be deemed appropriate by the Company. 

  

	 	14.4	 Legal Fees. In any dispute arise from or in connection with this Agreement, the winning party shall be
entitled to be reimbursed for reasonable legal fees. 

  

	 	14.5	 Amendments, Extension and Waiver. This Agreement may not be amended, revised, extended or terminated
unless by a written instrument executed by the Executive or a duly authorized representative of the Company (excluding the Executive). Any failure or delay to assert any right, remedy or power shall not be construed as a waiver of such right, remedy
or power. All rights and remedies existing under this Agreement are cumulative to, and not exclusive of, any rights or remedies otherwise available. 

  

	 	14.6	 Transfer; Successors and Assigns. The Executive agrees that he/she will not transfer, sell, assign or
otherwise dispose of (whether voluntarily, involuntarily or by operation of law) any rights or interests under this Agreement, and the rights of the Executive shall not be subject to any security interest or creditors’ claims. Any such
transfer, assign or other disposal shall be invalid. Nothing contained in this Agreement shall prevent the Company from merging into or with any other company or selling all or substantially all of the assets of the Company, or transfer this
Agreement or any obligation under this Agreement. In the event of any change in the ownership interest or the control of the Company, the provisions of this Agreement shall continue to apply and shall be binding upon any successors. Notwithstanding
and subject to the foregoing, this Agreement shall be valid and binding upon, and inure to the benefit of, the successor, representative, heirs and permitted assigns of each party, and shall not vest in any other individual or entity any interest.

  
 10 

	 	14.7	 Notice. All notices or other communications under this Agreement shall be made in writing and delivered
to the following addresses or any other addresses designated by each party in writing from time to time: 

 To the Company:

  

			
	 Address:
	 	30/F, Dicara Silver Tower
		 	29 Jiefang East Road
		 	Jianggan District, Hangzhou, 310016
		 	People’s Republic of China
		 	Attention: Chief Executive Officer

 To the Executive: 
  

	
	 Address:

	 Fax:

	 Attention of:

 Any notice shall be deemed to have been delivered: 

 

	 	(a)	 If by hand or courier, on the date of actual delivery; 

 

	 	(b)	 If by prepaid and registered mail, on the fourth business days after the date of dispatch; or

  

	 	(c)	 If by fax, on the date on which the fax is transmitted (as evidenced by the confirmatory report with fax
number, pages transmitted and date of transmission). 

  

	 	14.8	 Severability; Enforceability. If all or any portion of any provision of this Agreement as applied to any
person, to any place or to any circumstance shall be ruled by an arbitration commission or a court of competent jurisdiction to be invalid, illegal or incapable of being enforced, the same shall in no way affect (to the maximum extent permissible by
Law) that provision or the remaining portions of that provision as applied to any parties, places or circumstances or any other provisions of this Agreement or the validity or enforceability of this Agreement as a whole. 

 

	 	14.9	 Governing Law. This Agreement shall be governed and construed in accordance with the laws of the
People’s Republic of China. 

  

	 	14.10	 Language. This Agreement is written and executed in English. 

 

	 	14.11	 Originals. This Agreement is executed by the parties in two originals. Each of the parties will hold one
original, and the two originals shall be equally valid. 

  
 11 

 The Executive acknowledges that (a) he/she has consulted or has the opportunity to
consult with independent counsel of his choice regarding this Agreement, and the Company has suggested that he/she do so and (b) he/she has read and understands this Agreement, fully understands its legal effect, and has entered into this
Agreement voluntarily in his/her own judgment. The Executive hereby agrees that the obligations under Articles 7, 8 and 9 hereof and the definition of the Proprietary Information contained in those provisions shall also apply to the Proprietary
Information relating to any work performed for the Company prior to the execution of this Agreement. 
 [Signatures Page to Follow] 

  
 12 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed on the date first written above.

  

			
	CANAAN INC.

 
			
		
	By: 	 	 

 
			
	Name:	 	
	Title:	 	
	
	[EXECUTIVE]

 
			
		
	By: 	 	 

 
			
	Name:	 	

 EXHIBIT A 

Compensation 
 Part I. Base
Salary 
 Part II. Bonus 

EXHIBIT B 
 Prior
Inventions 
 [To be provided by the Executive]Exhibit 10.1

       

      REGISTRATION RIGHTS AGREEMENT

       

      THIS REGISTRATION RIGHTS AGREEMENT (“Agreement”) is entered into as of December 12, 2018 by and among Sport Endurance, Inc., a Nevada corporation (the “Company”), and_____________(the “Investor”).

       

      WHEREAS, the Company issued shares of its common stock and warrants to the Investor pursuant to a Securities Purchase Agreement of even date (the “Purchase Agreement”); and

       

      WHEREAS, the Company has agreed to provide certain registration rights to the Investor.

       

      NOW, THEREFORE, in consideration of the mutual promises and the covenants as set forth herein, the parties hereto hereby agree as follows:

       

      1.          Definitions. Unless the context otherwise requires, the terms defined
          in this Section 1 shall have the meanings herein specified for all purposes of this Agreement, applicable to both the singular and plural forms of any of the terms herein defined.

       

      “Agreement” means this Registration Rights Agreement, as the same may be amended, modified or supplemented in accordance with the terms hereof.

       

      “Common Stock” means the Company’s authorized common stock, as constituted on the date of this Agreement, any stock into which such Common Stock may thereafter be changed and any stock of
        the Company of any other class, which is not preferred as to dividends or assets over any other class of stock of the Company and which is not subject to redemption, issued to the holders of shares of such Common Stock upon any re-classification
        thereof.

       

      “Commission” means the Securities and Exchange Commission or any other governmental body at the time administering the Securities Act.

       

      “Company” has the meaning assigned to it in the introductory paragraph of this Agreement.

       

      “Exchange Act” means the Securities Exchange Act of 1934 (or successor statute).

       

      “Excluded Forms” means registration statements under the Securities Act, on Forms S-4 and S-8, or any successors thereto and any form used in connection with an initial public offering of
        securities.

       

      “Investor” has the meaning assigned to it in the introductory paragraph of this Agreement.

       

      “Other Shares” has the meaning assigned to it in Section 4(f) of this Agreement.

       

      “Person” includes any natural person, corporation, trust, association, company, partnership, joint venture, limited liability company and other entity and any government, governmental
        agency, instrumentality or political subdivision.

       

      “Purchase Agreement” has the meaning assigned to it in the first WHEREAS clause.

       

      
        
          

      

      
      The terms “register,” “registered” and “registration” refer to a registration effected by preparing and filing a registration statement on other than any of the Excluded Forms
        in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement.

       

      “Registrable Securities” means the Common Stock acquired by the Investor pursuant to the Purchase Agreement, the Common Stock issuable upon the exercise of Warrants, dated the same date as
        this Agreement, and any securities of the Company issued with respect to such Common Stock by way of a stock dividend or stock split or in connection with a combination, recapitalization, share exchange, consolidation or other reorganization of the
        Company.

       

      “Selling Expenses” means all selling commissions, finder’s fees and stock transfer taxes applicable to the Registrable Securities registered by the Investor and all fees and disbursements of
        counsel for the Investor.

       

      “Securities Act” means the Securities Act of 1933 (or successor statute).

       

      “Warrants” means the warrants to purchase Common Stock acquired by the Investor pursuant to the Purchase Agreement.

       

      2.          Required Registration. As soon as practicable following the date of
          this Agreement, but in any event not later than sixty (60) days from the date hereof, the Company shall use commercially reasonable efforts to file a registration statement on Form S-1 (or other applicable form) with the Commission in order to
          permit the Investor to publicly sell the Registrable Securities.

       

      3.           Obligations of the Company. If and whenever the Company is required
          by the provisions hereof to effect or cause the registration of any Registrable Securities under the Securities Act as provided herein, the Company shall:

       

      (a)         use commercially reasonable efforts to prepare and file with the Commission a registration statement with respect to
          such Registrable Securities and use commercially reasonable efforts to cause such registration statement to become and remain effective;

       

      (b)          use commercially reasonable efforts to prepare and file with the Commission such amendments to such registration
          statement (including post-effective amendments) and supplements to the prospectus included therein as may be necessary to keep such registration statement effective, subject to the qualifications in Section 4(a), and to comply with the provisions
          of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such registration statement during such period in accordance with the intended methods of disposition by the Investor  set forth in such
          registration statement;

       

      (c)           furnish to the Investor such number of copies of such registration statement and of each such amendment and
          supplement thereto (in each case including all exhibits), such number of copies of the prospectus included in such registration statement (including each preliminary prospectus), in conformity with the requirements of the Securities Act, and such
          other documents, as each Investor may reasonably request, in order to facilitate the public sale or other disposition of the Registrable Securities owned by the Investor;

       

      
        2

        
          

      

      (d)          use all commercially reasonable efforts to make such filings under the securities or blue sky laws of the State of
          New York to enable the Investor to consummate the sale in such jurisdiction of the Registrable Securities owned by the Investor;

       

      (e)            notify the Investor at any time when a prospectus relating to their Registrable Securities is required to be
          delivered under the Securities Act, of the Company’s becoming aware that the prospectus included in the related registration statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact
          required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly prepare and furnish to the Investor a reasonable number of copies of a prospectus supplemented or
          amended so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to
          make the statements therein not misleading in the light of the circumstances then existing;

       

      (f)             otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the
          Commission;

       

      (g)           to use commercially reasonable efforts to cause Registrable Securities to be quoted on each trading market and/or
          in each quotation service on which the Common Stock of the Company is then quoted; and

       

      (h)           notify the Investor of any stop order threatened or issued by the Commission and take all actions reasonably
          necessary to prevent the entry of such stop order or to remove it if entered.

       

      4.           Other Procedures.

       

      (a)          Subject to the Company’s general obligation to use commercially reasonable efforts under Section 3, the Company shall
          be required to maintain the effectiveness of a registration statement (on Form S-1 or other applicable form) until the earlier of (i) the sale of all Registrable Securities or (ii) two years from the effective date of the registration statement.
          The Company shall have no liability to the Investor for delays in the Investor being able to sell the Registrable Securities (i) as long as the Company uses commercially reasonable efforts to file a registration statement, amendments to the
          registration statement or supplements to a prospectus contained in a registration statement (including any amendment or post effective amendments), (ii) where the required financial statements or auditor’s consents are unavailable or (iii) where
          the Company would be required to disclose information at a time when it has no duty to disclose such information under the Securities Act, the Exchange Act, or the rules and regulations of the Commission.

       

      (b)            In consideration of the Company’s obligations under this Agreement, the Investor agrees that, upon receipt of any
          notice from the Company of the happening of any event of the kind described in Section 3(e) herein, the Investor shall forthwith discontinue his sale of Registrable Securities pursuant to the registration statement covering such Registrable
          Securities until the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by said Section 3(e) and, if so directed by the Company, shall deliver to the Company (at the Company’s expense) all copies, other than
          permanent file copies, then in the Investor’s possession of the prospectus covering such Registrable Securities current at the time of receipt of such notice.

       

      
        3

        
          

      

      (c)           The Company’s obligation to file any registration statement or amendment including a post-effective amendment,
          shall be subject to each Investor, as applicable, furnishing to the Company in writing such information and documents regarding such Investor and the distribution of such Investor’s Registrable Securities as may reasonably be required to be
          disclosed in the registration statement in question by the rules and regulations under the Securities Act or under any other applicable securities or blue sky laws of the jurisdiction referred to in Section 3(d) herein. The Company’s obligations
          are also subject to each Investor promptly executing any representation letter concerning compliance with Regulation M under the Exchange Act (or any successor rule or regulation).

       

      (d)          If any such registration or comparable statement refers to the Investor by name or otherwise as a stockholder of the
          Company, but such reference to the Investor by name or otherwise is not required by the Securities Act or the rules thereunder, then each Investor shall have the right to require the deletion of the reference to the Investor, as may be
          applicable.

       

      (e)           In connection with the sale of Registrable Securities, the Investor shall deliver to each purchaser a copy of the
          necessary prospectus and, if applicable, prospectus supplement, within the time required by Section 5(b) of the Securities Act.

       

      5.           Registration Expenses. In connection with any registration of
          Registrable Securities pursuant to Section 2, the Company shall, whether or not any such registration shall become effective, from time to time, pay all expenses (other than Selling Expenses) incident to its performance of or compliance,
          including, without limitation, all registration, and filing fees, fees and expenses of compliance with securities or blue sky laws, word processing, printing and copying expenses, messenger and delivery expenses, fees and disbursements of counsel
          for the Company and all independent public accountants and other Persons retained by the Company.

       

      6.           Indemnification.

       

      (a)          In the event of any registration of any shares of Common Stock under the Securities Act pursuant to this Agreement,
          the Company shall indemnify and hold harmless each Investor, from and against any losses, claims, damages or liabilities, joint or several, to which each Investor may become subject under the Securities Act or otherwise, insofar as such losses,
          claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in any registration statement under which such Registrable Securities were
          registered under the Securities Act, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereto, or any document incident to registration or qualification of any Registrable Securities pursuant to
          Section 3(d) herein, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or, with respect to any prospectus,
          necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or any violation by the Company of the Securities Act, the Exchange Act, or state securities or blue sky laws applicable to the
          Company and relating to action or inaction required of the Company in connection with such registration or qualification under the Securities Act or such state securities or blue sky laws. If the Company fails to defend the Investor as required
          by Section 6(c) herein, it shall reimburse (after receipt of appropriate documentation) each Investor for any legal or any other out-of-pocket expenses reasonably incurred by any of them in connection with investigating or defending any such
          loss, claim, damage, liability or action; provided, however, that the Company shall not be liable to an Investor in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon (i) an
          untrue statement or alleged untrue statement or omission or alleged omission made in said registration statement, said preliminary prospectus, said prospectus, or said amendment or supplement or any document incident to registration or
          qualification of any Registrable Securities pursuant to Section 3(d) hereof in reliance upon and in conformity with written information furnished to the Company by such Investor specifically for use in the preparation thereof or information
          omitted to be furnished by such Investor or (ii) any act or failure to act of such Investor including the failure of any Investor to deliver a prospectus as required by Section 5(b) of the Securities Act.

       

      
        4

        
          

      

      (b)         In the event of any registration of any Registrable Securities under the Securities Act pursuant to this Agreement,
          each Investor shall indemnify and hold harmless (in the same manner and to the same extent as set forth in Section 6(a)) the Company, each director of the Company, each officer of the Company who signs such registration statement, the Company’s
          attorneys and auditors and any Person who controls the Company within the meaning of the Securities Act, with respect to (i) any untrue statement or omission from such registration statement, any preliminary prospectus or final prospectus
          contained therein, or any amendment or supplement thereto, if such untrue statement or omission was made in reliance upon and in conformity with written information furnished to the Company by such Investor specifically for use in the preparation
          of such registration statement, preliminary prospectus, final prospectus or amendment or supplement or (ii) from any other act or failure to act of the Investor.

       

      (c)            Promptly after receipt by an indemnified party of notice of the commencement of any action involving a claim
          referred to in Section 6(a) or (b), such indemnified party shall, if a claim in respect thereof is made against an indemnifying party, give written notice to the Indemnifying Party of the commencement of such action. The indemnifying party shall
          be relieved of its obligations under this Section 6(c) to the extent that the indemnified party delays in giving notice and the indemnifying party is damaged or prejudiced by the delay. In case any such action is brought against an indemnified
          party, the indemnifying party shall be entitled to participate in and to assume the defense thereof, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to such
          indemnified party, and, after notice from the indemnifying party to such indemnified party of its election so as to assume the defense thereof, the indemnifying party shall be responsible for any legal or other expenses subsequently incurred by
          the indemnifying party in connection with the defense thereof, provided, however, that, if counsel for an indemnified party shall have reasonably concluded that there is an actual or potential conflict of interest between the
          indemnified and the indemnifying party the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified party, and such indemnifying party shall reimburse such indemnified party and any Person
          controlling such indemnified party for the fees and expenses of counsel retained by the indemnified party which are reasonably related to the matters covered by the indemnity agreement provided in this Section 6; provided, however,
          that in no event shall any indemnification by an Investor under this Section 6 exceed the net proceeds from the sale of Registered Securities received by the Investor. No indemnified party shall make any settlement  of any claims indemnified
          against hereunder without the written consent of the indemnifying party, which consent shall not be unreasonably withheld. In the event that any indemnifying party enters into any settlement without the written consent of the indemnified party
          the indemnifying party shall not, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff of a release of such indemnified party from all
          liability in respect to such claim or litigation.

       

      
        5

        
          

      

      (d)           In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in
          which under any indemnified party makes a claim for indemnification pursuant to this Section 6, but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal
          or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Section 6 provides for indemnification in such case, or (ii) contribution under the Securities Act may be
          required in circumstances for which indemnification is provided under this Section 6; then, in each such case, the Company and such Investor shall contribute to the aggregate losses, claims, damages or liabilities to which they may be subject as
          is appropriate to reflect the relative fault of the Company and such Investor in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities, it being understood that the parties acknowledge that the
          overriding equitable consideration to be given effect in connection with this provision is the ability of one party or the other to correct the statement or omission (or avoid the conduct or take an act) which resulted in such losses, claims,
          damages or liabilities, and that it would not be just and equitable if contribution pursuant hereto were to be determined by pro-rata allocation or by any other method of allocation which does not take into consideration the foregoing equitable
          considerations. Notwithstanding the foregoing, (i) no such Investor shall be required to contribute any amount in excess of the net proceeds to him of all Registrable Securities sold by him pursuant to such registration statement, and (ii) no
          Person who is guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation.

       

      (e)            Notwithstanding any of the foregoing, if, in connection with an underwritten public offering of the Registrable
          Securities, the Company, any of the Investor and the underwriters enter into an underwriting agreement relating to such offering which contains provisions covering indemnification among the parties, then the indemnification provision of this
          Section 6 shall be deemed inoperative for purposes of such offering.

       

      7.           Certain Limitations on Registration Rights. At any time prior to the
          effectiveness of any registration statement filed pursuant to this Agreement, if the Company determines to file a registration statement with the Commission for the public sale of its securities and the managing underwriter of such offering
          offers to purchase the Registrable Securities for its own account at the same price including underwriting discounts and applicable expenses as paid to the Company, the Investor shall either (i) elect to include their Registrable Securities being
          registered pursuant to this Agreement in the registration statement covering the sale of the Company’s securities, or (ii) immediately cease their public sales for a period of 90 days following the effective date of the registration statement
          covering the sale by the Company. Additionally, no Investor may participate in the registration statement relating to the sale by the Company of its Common Stock as provided above unless such Investor enters into an underwriting agreement with
          the managing underwriter and completes and/or executes all questionnaires, indemnities and other reasonable documents requested by the managing underwriter. Each Investor shall be deemed to have agreed by acquisition of its Registrable Securities
          not to effect any public sale or distribution, including any sale pursuant to Rule 144 under the Securities Act, of any Registrable Securities and to use its best efforts not to effect any such public sale or distribution of any other equity
          security of the Company (including any short sale) or of any security convertible into or exchangeable or exercisable for any equity security of the Company (other than as part of such underwritten public offering) within 10 days before or 90
          days after the effective date of such registration statement. In such event, the Investor shall, if requested, sign a customary market stand-off letter with the Company’s managing underwriter, and to comply with applicable rules and regulations
          of the Commission.

       

      
        6

        
          

      

      8.          Allocation of Securities Included in Registration Statement. In the
          case of a registration pursuant to Section 7 for the Company’s account, if the Company’s managing underwriter shall advise the Company and the Investor in writing that the inclusion in any registration pursuant hereto of some or all of (a) the
          Registrable Securities sought to be registered by the Investor and securities offered by other holders, and (b) the Company’s securities sought to be registered creates a substantial risk that the proceeds or price per unit that will be derived
          from such registration will be reduced or that the number of securities to be registered is too large a number to be reasonably sold, (i) first, the number of Company securities sought to be registered shall be included in such registration, and
          (ii) next, the number of Registrable Securities offered by the Investor and securities offered by other holders shall be included in such registration to  the extent permitted by the Company’s managing underwriter with the number of Registrable
          Securities and such other securities being registered determined on a pro-rata basis based on the number of Registered Securities and securities the participating holders including the Investor desire to have registered; provided, however,
          that, if any participating Investor would be required pursuant to the provisions of this Section 7 to reduce the number of Registrable Securities that he may include in such registration, the Investor may withdraw all or any portion of its
          Registrable Securities from such registration and may resume selling shares under the registration statement (assuming it is effective) referred to in Section 2 after the 90-day lock-up period.

       

      9.          Rule 144. The Company covenants that it will file the reports required
          to be filed under the Securities Act and the Exchange Act and the rules and regulations adopted by the Commission thereunder (or, in the event that the Company is not required to file such reports, it will make publicly available information as
          set forth in Rule 144(c)(2) promulgated under the Securities Act), and it will take such further action as the Investor may reasonably request, or to the extent required from time to time to enable the Investor to sell their Registrable
          Securities without registration under the Securities Act within the limitation of the exemption provided by (a) Rule 144 under the Securities Act, as such Rule may be amended from time to time, or (b) any similar rule or regulation hereafter
          adopted by the Commission (collectively, “Rule 144”). Upon request of any Investor, the Company will deliver to the Investor a written statement as to whether it has complied with such requirements.

       

      
        7

        
          

      

      10.         Severability. In the event any parts of this Agreement are found to be
          void, the remaining provisions of this Agreement shall nevertheless be binding with the same effect as though the void parts were deleted.

       

      11.         Counterparts. This Agreement may be executed in one or more
          counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

       

      12.          Benefit. This Agreement shall be binding upon and inure to the
          benefit of the parties hereto and their legal representatives, successors and assigns.

       

      13.        Notices and Addresses. All notices, offers, acceptance and any other
          acts under this Agreement (except payment) shall be in writing, and shall be sufficiently given if delivered to the addressees in person, by Federal Express or similar overnight next business day delivery, or by email delivery followed by
          overnight next business day delivery as follows:

       

      	
              To the Company:

            	
              Sport Endurance, Inc.

            
	 	
              222 Broadway, 19th Floor

            
	 	
              New York, NY 10038

            
	 	
              Attention: David Lelong

            
	 	
              Email: david@sportendurancehq.com

            
	 	 
	
              With a Copy to:

            	
              Nason, Yeager, Gerson, Harris & Fumero, P.A.

            
	 	
              3001 PGA Boulevard, Suite 305

            
	 	
              Palm Beach Gardens, FL 33410

            
	 	
              Attention: Michael D. Harris, Esq.

            
	 	
              Email: mharris@nasonyeager.com

            

       

      

      To the Investor, to: the address and email address listed on the signature page hereto.

       

      or to such other address as any of them, by notice to the other may designate from time to time. The transmission confirmation receipt from the sender’s facsimile machine shall be evidence of successful facsimile delivery.  Time shall be counted
        from the date of transmission.

       

      14.        Attorneys’ Fees. In the event that there is any controversy or claim
          arising out of or relating to this Agreement, or to the interpretation, breach or enforcement thereof, and any action or proceeding relating to this Agreement is filed, the prevailing party shall be entitled to an award by the court of reasonable
          attorneys’ fees, costs and expenses.

       

      15.         Oral Evidence. This Agreement constitutes the entire Agreement between
          the parties and supersedes all prior oral and written agreements between the parties hereto with respect to the subject matter hereof. Neither this Agreement nor any provision hereof may be changed, waived, discharged or terminated orally, except
          by a statement in writing signed by the party or parties against which enforcement or the change, waiver discharge or termination is sought.

       

      16.         Additional Documents. The parties hereto shall execute such additional
          instruments as may be reasonably required by their counsel in order to carry out the purpose and intent of this Agreement and to fulfill the obligations of the parties hereunder.

       

      
        8

        
          

      

      17.        Governing Law. This Agreement and any dispute, disagreement, or issue
          of construction or interpretation arising hereunder whether relating to its execution, its validity, the obligations provided herein or performance shall be governed or interpreted according to the internal laws of the State of Nevada without
          regard to choice of law considerations.

       

      18.         Section or Paragraph Headings. Section headings herein have been
          inserted for reference only and shall not be deemed to limit or otherwise affect, in any matter, or be deemed to interpret in whole or in part any of the terms or provisions of this Agreement.

       

      19.        Force Majure. The Company shall be excused from any delay in
          performance or for non-performance of any of the terms and conditions of this Agreement caused by any circumstances beyond its control, including, but not limited to, any Act of God, fire, flood, or government regulation, direction or request, or
          accident, interruption of telecommunications facilities, labor dispute, unavoidable breakdown, civil unrest or disruption to the extent that any such circumstances affect the Company’s ability to perform its obligations under this Agreement or
          the ability of the Commission to perform its responsibilities under the Securities Act.

       

      [Signature Page Follows]

       

      
        9

        
          

      

      IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed personally or by a duly authorized representative thereof as of the day and year first above written.

       

      	 	
              SPORT ENDURANCE, INC.

            
	 	
              By:

            	 	 
	 	
              Name:

            	
              David Lelong

            
	 	
              Title:

            	
              Chief Executive Officer

            
	 	 	 
	 	
              INVESTOR

            
	 	 
	 	 
	 	
              Signature

            
	 	 
	 	 
	 	
              Printed Name of Investor

            
	 	 
	 	 
	 	
              Title of Authorized Signatory if Investor

            
	 	
              is a corporation or other entity

            
	 	 
	 	 
	 	
              Signature of spouse or co-owner, if any

            
	 	 
	 	 
	 	
              Address

            
	 	 
	 	 
	 	
              Email

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00301-of-00352.parquet"}]]